Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 26;40(1):177.
doi: 10.1186/s13046-021-01973-z.

Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis

Affiliations

Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis

Lin-Pei Wang et al. J Exp Clin Cancer Res. .

Retraction in

Abstract

Background: Hepatocellular carcinoma (HCC) cells-secreted exosomes (exo) could stimulate M2 macrophage polarization and promote HCC progression, but the related mechanism of long non-coding RNA distal-less homeobox 6 antisense 1 (DLX6-AS1) with HCC-exo-mediated M2 macrophage polarization is largely ambiguous. Thereafter, this research was started to unearth the role of DLX6-AS1 in HCC-exo in HCC through M2 macrophage polarization and microRNA (miR)-15a-5p/C-X-C motif chemokine ligand 17 (CXCL17) axis.

Methods: DLX6-AS1, miR-15a-5p and CXCL17 expression in HCC tissues and cells were tested. Exosomes were isolated from HCC cells with overexpressed DLX6-AS1 and co-cultured with M2 macrophages. MiR-15a-5p/CXCL17 down-regulation assays were performed in macrophages. The treated M2 macrophages were co-cultured with HCC cells, after which cell migration, invasion and epithelial mesenchymal transition were examined. The targeting relationships between DLX6-AS1 and miR-15a-5p, and between miR-15a-5p and CXCL17 were explored. In vivo experiment was conducted to detect the effect of exosomal DLX6-AS1-induced M2 macrophage polarization on HCC metastasis.

Results: Promoted DLX6-AS1 and CXCL17 and reduced miR-15a-5p exhibited in HCC. HCC-exo induced M2 macrophage polarization to accelerate migration, invasion and epithelial mesenchymal transition in HCC, which was further enhanced by up-regulated DLX6-AS1 but impaired by silenced DLX6-AS1. Inhibition of miR-15a-5p promoted M2 macrophage polarization to stimulate the invasion and metastasis of HCC while that of CXCL17 had the opposite effects. DLX6-AS1 mediated miR-15a-5p to target CXCL17. DLX6-AS1 from HCC-exo promoted metastasis in the lung by inducing M2 macrophage polarization in vivo.

Conclusion: DLX6-AS1 from HCC-exo regulates CXCL17 by competitively binding to miR-15a-5p to induce M2 macrophage polarization, thus promoting HCC migration, invasion and EMT.

Keywords: C-X-C motif chemokine ligand 17; Hepatocellular carcinoma; Hepatocellular carcinoma cell-secreted exosomes; Long non-coding RNA distal-less homeobox 6 antisense 1; M2 macrophages; microRNA-15a-5p.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
HCC-exo induce macrophage M2 polarization. a. Electron microscope observation of the morphology of SMMC-7721 cells-derived exosomes; b. Western blot analysis of antigens (CD63, Alix and TSG101) in SMMC-7721 cells-derived exosomes; c. Microscopic observation of THP1 cells before and after PMA induction; d. PKH26 labeling of exosomes; e. RT-qPCR detection of M2 macrophages markers (CD206, CD163, CCL17 and CCL18) after co-culture with HCC-exo; f. RT-qPCR detection of M1 macrophages markers (TNF-α, IL-6 and TGF-β) after co-culture with HCC-exo; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. & P < 0.05 compared with the PBS group
Fig. 2
Fig. 2
HCC-exo promote migration, invasion and EMT via inducing M2 macrophage polarization in HCC. a. Transwell assay tested the invasion and migration of SMMC-7721 cells after co-culture with HCC-exo-treated macrophages; b. Transwell assay tested the invasion and migration of HepG2 cells after co-culture with HCC-exo-treated macrophages; c. RT-qPCR analysis of E-cadherin, N-cadherin, vimentin and MMP7 mRNA expression in SMMC-7721 and HepG2 cells after co-culture with HCC-exo-treated macrophages; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. * P < 0.05 compared with the SMMC-7721 + M group; ^ P < 0.05 compared with the HepG2 + M group
Fig. 3
Fig. 3
DLX6-AS1 is overexpressed and triggers migration, invasion and EMT in HCC. a. RT-qPCR detection of DLX6-AS1 expression in cancer tissues and normal tissues, as well as cancer cells and normal liver cells; b. RT-qPCR detection of DLX6-AS1 expression in SMMC-7721 and HepG2 cells after up-regulating DLX6-AS1; c. Transwell assay tested the invasion and migration of SMMC-7721 cells after up-regulating DLX6-AS1; d. Transwell assay tested the invasion and migration of HepG2 cells after up-regulating DLX6-AS1; e. RT-qPCR analysis of E-cadherin, N-cadherin, vimentin and MMP7 mRNA expression in SMMC-7721 and HepG2 cells after up-regulating DLX6-AS1; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. $ P < 0.05 compared with the HL-7702 cells; * P < 0.05 compared with the oe-NC group
Fig. 4
Fig. 4
DLX6-AS1 from HCC-exo stimulates M2 macrophage polarization to accelerate migration, invasion and EMT in HCC. a. RT-qPCR detection of DLX6-AS1 expression in serum of HCC patients and healthy controls; b. Detection of CD68 expression in clinical samples through immunohistochemical staining; c. Correlation between expression of DLX6-AS1 and CD68 was analyzed using Pearson test; d. RT-qPCR detection of DLX6-AS1 expression in HCC-exo delivering oe-DLX6-AS1; e. RT-qPCR detection of DLX6-AS1 expression in macrophages after co-culture with HCC-exo delivering oe-DLX6-AS1; f. RT-qPCR detection of M2 macrophages markers (CD206, CD163, CCL17 and CCL18) after co-culture with HCC-exo carrying oe-DLX6-AS1; g. RT-qPCR detection of M1 macrophages markers (TNF-α, IL-6 and TGF-β) after co-culture with HCC-exo carrying oe-DLX6-AS1; h. Transwell assay tested the migration and invasion of SMMC-7721 cells after co-culture with M2 macrophages induced by HCC-exo carrying oe-DLX6-AS1; i. Transwell assay tested the migration and invasion of HepG2 cells after co-culture with M2 macrophages induced by HCC-exo delivering oe-DLX6-AS1; j. RT-qPCR of E-cadherin, N-cadherin, vimentin and MMP7 mRNA expression in SMMC-7721 and HepG2 cells after co-culture with M2 macrophages induced by HCC-exo delivering oe-DLX6-AS1; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. * P < 0.05 compared with the oe-NC group; # P < 0.05 compared with the PBS group; & P < 0.05 compared with the oe-NC-exo group; ^ P < 0.05 compared with the oe-NC-exo + M group
Fig. 5
Fig. 5
DLX6-AS1 from HCC-exo stimulates M2 macrophage polarization to accelerate migration, invasion and EMT in HCC. a. RT-qPCR detection of DLX6-AS1 expression in HCC-exo delivering sh-DLX6-AS1; b. RT-qPCR detection of DLX6-AS1 expression in macrophages after co-culture with HCC-exo delivering sh-DLX6-AS1; c. RT-qPCR detection of M2 macrophages markers (CD206, CD163, CCL17 and CCL18) after co-culture with HCC-exo carrying sh-DLX6-AS1; d. RT-qPCR detection of M1 macrophages markers (TNF-α, IL-6 and TGF-β) after co-culture with HCC-exo carrying sh-DLX6-AS1; e. Transwell assay tested the migration and invasion of SMMC-7721 cells after co-culture with M2 macrophages induced by HCC-exo carrying sh-DLX6-AS1; f. Transwell assay tested the migration and invasion of HepG2 cells after co-culture with M2 macrophages induced by HCC-exo delivering sh-DLX6-AS1; g/h. RT-qPCR of E-cadherin, N-cadherin, vimentin and MMP7 mRNA expression in SMMC-7721 and HepG2 cells after co-culture with M2 macrophages induced by HCC-exo delivering sh-DLX6-AS1; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. ^P < 0.05 compared with the sh-NC group; *P < 0.05 compared with the oe-NC-exo group; + P < 0.05 compared with the oe-NC-exo + M group
Fig. 6
Fig. 6
DLX6-AS1 interacts with miR-15a-5p. a. RT-qPCR detection of miR-15a-5p expression in cancer tissues and normal tissues; b. RT-qPCR detection of miR-15a-5p expression in cancer cells and normal liver cells; c. RT-qPCR detection of miR-15a-5p expression in macrophages after co-culture with HCC-exo delivering oe-DLX6-AS1; d. Prediction of the potential binding sites of DLX6-AS1 and miR-15a-5p through bioinformatics websites; e. Verification of the targeting relationship between DLX6-AS1 and miR-15a-5p through dual luciferase reporter experiment; f. RIP detection of the binding relationship between DLX6-AS1 and miR-15a-5p; g. RNA pull-down detection of the binding relationship between DLX6-AS1 and miR-15a-5p; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. * P < 0.05 compared with the oe-NC-exo group
Fig. 7
Fig. 7
Down-regulating miR-15a-5p promotes M2 macrophage polarization and HCC cell migration, invasion and EMT. a. RT-qPCR detection of miR-15a-5p expression in macrophages after down-regulating miR-15a-5p; b. RT-qPCR detection of M2 macrophages markers (CD206, CD163, CCL17 and CCL18) after down-regulating miR-15a-5p; c. RT-qPCR detection of M1 macrophages markers (TNF-α, IL-6 and TGF-β) after down-regulating miR-15a-5p; d. Transwell assay tested the migration and invasion of SMMC-7721 cells after co-culture with macrophages inhibiting miR-15a-5p; e. Transwell assay tested the migration and invasion of HepG2 cells after co-culture with macrophages inhibiting miR-15a-5p; f. E-cadherin, N-cadherin, vimentin and MMP7 expression in SMMC-7721 and HepG2 cells after co-culture with macrophages inhibiting miR-15a-5p by qPCR; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. % P < 0.05 compared with the NC-inhibitor group; + P < 0.05 compared with the NC-inhibitor + M group
Fig. 8
Fig. 8
DLX6-AS1 mediates miR-15a-5p to target CXCL17 to drive migration, invasion and EMT in HCC. a. RT-qPCR analysis of CXCL17 expression in clinical tissues; b. RT-qPCR and Western blot analysis of CXCL17 expression in cancer cells and normal liver cells; c. RT-qPCR and Western blot analysis of CXCL17 expression in macrophages after down-regulating miR-15a-5p; d. Prediction of the potential binding site of miR-15a-5p and CXCL17 through bioinformatics websites; e. Verification of the targeting relationship between miR-15a-5p and CXCL17 through dual luciferase reporter experiment; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. $ P < 0.05 compared with HL-7702 cells; & P < 0.05 compared with the NC-inhibitor group
Fig. 9
Fig. 9
DLX6-AS1 mediates miR-15a-5p to target CXCL17 to drive migration, invasion and EMT in HCC. a. RT-qPCR and Western blot analysis of CXCL17 expression in macrophages after silencing CXCL17; b. RT-qPCR detection of M2 macrophages markers (CD206, CD163, CCL17 and CCL18) after silencing CXCL17; c. RT-qPCR detection of M1 macrophages markers (TNF-α, IL-6 and TGF-β) after silencing CXCL17;d. Transwell assay tested the migration and invasion of SMMC-7721 cells after co-culture with macrophages inhibiting CXCL17; e. Transwell assay tested the migration and invasion of HepG2 cells after co-culture with macrophages inhibiting CXCL17; f. E-cadherin, N-cadherin, vimentin and MMP7 mRNA expression in SMMC-7721 and HepG2 cells after co-culture with macrophages inhibiting CXCL17; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test; % P < 0.05 compared with the si-NC group; + P < 0.05 compared with the si-NC + M group
Fig. 10
Fig. 10
DLX6-AS1 mediates miR-15a-5p to target CXCL17 to drive migration, invasion and EMT in HCC. a. RT-qPCR analysis of CXCL17 expression in macrophages; b. RT-qPCR detection of M2 macrophages markers (CD206, CD163, CCL17 and CCL18); c. RT-qPCR detection of M1 macrophages markers (TNF-α, IL-6 and TGF-β); d. Transwell assay tested the migration and invasion of SMMC-7721 cells; e. Transwell assay tested the migration and invasion of HepG2 cells; f/g. E-cadherin, N-cadherin, vimentin and MMP7 mRNA expression in SMMC-7721 and HepG2 cells; data were expressed as mean ± standard deviation (repetition = 3) and evaluated by One-way AVONA and Tukey’s test. ^ P < 0.05 compared with the oe-DLX6-AS1-exo + si-NC group; + P < 0.05 compared with theoe-DLX6-AS1-exo + si-NC+ M group
Fig. 11
Fig. 11
DLX6-AS1 from HCC-exo promotes lung metastasis by inducing M2 macrophages in mice with HCC. a. H&E-stained tumor tissues (200 ×); b. Number of metastatic hepatic nodules; data were as the mean ± standard deviation (mice = 6/group) and evaluated by One-way AVONA and Tukey’s test

Similar articles

Cited by

References

    1. Vyas M, Zhang X. Hepatocellular carcinoma: role of pathology in the era of precision medicine. Clin Liver Dis. 2020;24(4):591–610. doi: 10.1016/j.cld.2020.07.010. - DOI - PubMed
    1. Roderburg C, Wree A, Demir M, Schmelzle M, Tacke F. The role of the innate immune system in the development and treatment of hepatocellular carcinoma. Hepat Oncol. 2020;7(1):HEP17. doi: 10.2217/hep-2019-0007. - DOI - PMC - PubMed
    1. Trevisan Franca de Lima L, et al. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188451. doi: 10.1016/j.bbcan.2020.188451. - DOI - PubMed
    1. Feng M, et al. Therapy of Primary Liver Cancer. Innovation (N Y) 2020;1(2):100032. - PMC - PubMed
    1. Lopez-Janeiro A, et al. Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis. Mod Pathol. 2020;33(8):1458–1465. doi: 10.1038/s41379-020-0534-z. - DOI - PubMed

Publication types

MeSH terms